International Journal of Endocrinology and Metabolism

Published by: Neoscriber Demo Publisher

Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study

Firoozeh Hosseini-Esfahani 1 , Zahra Bahadoran 1 , Nazanin Moslehi 1 , Golaleh Asghari 1 , Emad Yuzbashian 1 , Somayeh Hosseinpour-Niazi 1 , Parvin Mirmiran 1 , ** and Fereidoun Azizi 2 , *
Authors Information
1 Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Corresponding Authors:
Article information
  • International Journal of Endocrinology and Metabolism: October 2018, 16 (4 (Suppl)); e84771
  • Published Online: October 21, 2018
  • Article Type: Review Article
  • Received: September 1, 2018
  • Revised: October 2, 2018
  • Accepted: October 7, 2018
  • DOI: 10.5812/ijem.84771

To Cite: Hosseini-Esfahani F , Bahadoran Z, Moslehi N , Asghari G , Yuzbashian E, et al. Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study, Int J Endocrinol Metab. 2018 ; 16(4 (Suppl)):e84771. doi: 10.5812/ijem.84771.

Abstract
Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011;9:48. doi: 10.1186/1741-7015-9-48. [PubMed: 21542944]. [PubMed Central: PMC3115896].
  • 2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi: 10.1007/s11906-018-0812-z. [PubMed: 29480368]. [PubMed Central: PMC5866840].
  • 3. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092-7. doi: 10.2337/dc08-1800. [PubMed: 19279302]. [PubMed Central: PMC2681035].
  • 4. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2003;61(1):29-37. doi: 10.1016/S0168-8227(03)00066-4. [PubMed: 12849921].
  • 5. Hosseinpanah F, Nazeri P, Ghareh S, Tohidi M, Azizi F. Predictors of the incident metabolic syndrome in healthy obese subjects: A decade of follow-up from the Tehran lipid and glucose study. Eur J Clin Nutr. 2014;68(3):295-9. doi: 10.1038/ejcn.2013.142. [PubMed: 23963276].
  • 6. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr. 2017;6(4):397-407. doi: 10.21037/tp.2017.10.02. [PubMed: 29184820]. [PubMed Central: PMC5682379].
  • 7. Misra A, Khurana L, Vikram NK, Goel A, Wasir JS. Metabolic syndrome in children: Current issues and South Asian perspective. Nutrition. 2007;23(11-12):895-910. doi: 10.1016/j.nut.2007.08.018. [PubMed: 17936199].
  • 8. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10:5. doi: 10.1186/1745-6215-10-5. [PubMed: 19166627]. [PubMed Central: PMC2656492].
  • 9. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: Rreport of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426-8. [PubMed: 20804311].
  • 10. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251-7. doi: 10.1016/j.diabres.2006.12.001. [PubMed: 17234299].
  • 11. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore. 2009;38(2):142-9. [PubMed: 19271043].
  • 12. Hadaegh F, Zabetian A, Harati H, Azizi F. Metabolic syndrome in normal-weight Iranian adults. Ann Saudi Med. 2007;27(1):18-24. doi: 10.5144/0256-4947.2007.18. [PubMed: 17277499]. [PubMed Central: PMC6077028].
  • 13. Hosseinpanah F, Barzin M, Amiri P, Azizi F. The trends of metabolic syndrome in normal-weight Tehranian adults. Ann Nutr Metab. 2011;58(2):126-32. doi: 10.1159/000327147. [PubMed: 21540582].
  • 14. Zabetian A, Hadaegh F, Sarbakhsh P, Azizi F. Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study. BMC Public Health. 2009;9:138. doi: 10.1186/1471-2458-9-138. [PubMed: 19435528]. [PubMed Central: PMC2696430].
  • 15. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One. 2013;8(9). e76304. doi: 10.1371/journal.pone.0076304. [PubMed: 24086723]. [PubMed Central: PMC3785433].
  • 16. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F. High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring). 2006;14(3):377-82. doi: 10.1038/oby.2006.50. [PubMed: 16648607].
  • 17. Afkhami-Ardekani M, Zahedi-Asl S, Rashidi M, Atifah M, Hosseinpanah F, Azizi F. Incidence and trend of a metabolic syndrome phenotype among Tehranian adolescents: Findings from the Tehran lipid and glucose study, 1998-2001 to 2003-2006. Diabetes Care. 2010;33(9):2110-2. doi: 10.2337/dc09-0023. [PubMed: 20519656]. [PubMed Central: PMC2928373].
  • 18. Asghari G, Eftekharzadeh A, Hosseinpanah F, Ghareh S, Mirmiran P, Azizi F. Instability of different adolescent metabolic syndrome definitions tracked into early adulthood metabolic syndrome: Tehran lipid and glucose study (TLGS). Pediatr Diabetes. 2017;18(1):59-66. doi: 10.1111/pedi.12349. [PubMed: 26825860].
  • 19. Heidari Z, Hosseinpanah F, Mehrabi Y, Safarkhani M, Azizi F. Predictive power of the components of metabolic syndrome in its development: A 6.5-year follow-up in the Tehran lipid and glucose study (TLGS). Eur J Clin Nutr. 2010;64(10):1207-14. doi: 10.1038/ejcn.2010.111. [PubMed: 20588290].
  • 20. Hosseinpanah F, Barzin M, Mirmiran P, Azizi F. Effect of changes in waist circumference on metabolic syndrome over a 6.6-year follow-up in Tehran. Eur J Clin Nutr. 2010;64(8):879-86. doi: 10.1038/ejcn.2010.79. [PubMed: 20485305].
  • 21. Mirmiran P, Noori N, Azizi F. A prospective study of determinants of the metabolic syndrome in adults. Nutr Metab Cardiovasc Dis. 2008;18(8):567-73. doi: 10.1016/j.numecd.2007.06.002. [PubMed: 18068961].
  • 22. Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R, et al. Paediatric metabolic syndrome and associated anthropometric indices: The CASPIAN Study. Acta Paediatr. 2006;95(12):1625-34. doi: 10.1080/08035250600750072. [PubMed: 17129973].
  • 23. Prakaschandra R, Naidoo DP. Increased waist circumference is the main driver for the development of the metabolic syndrome in South African Asian Indians. Diabetes Metab Syndr. 2017;11 Suppl 1:S81-5. doi: 10.1016/j.dsx.2016.12.011. [PubMed: 28024832].
  • 24. Ying X, Jiang Y, Qin G, Qian Y, Shen X, Jiang Z, et al. Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population. Medicine (Baltimore). 2017;96(10). e6289. doi: 10.1097/MD.0000000000006289. [PubMed: 28272253]. [PubMed Central: PMC5348201].
  • 25. Asghar A, Sheikh N. Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol. 2017;315:18-26. doi: 10.1016/j.cellimm.2017.03.001. [PubMed: 28285710].
  • 26. Rothberg AE, McEwen LN, Kraftson AT, Ajluni N, Fowler CE, Nay CK, et al. Impact of weight loss on waist circumference and the components of the metabolic syndrome. BMJ Open Diabetes Res Care. 2017;5(1). e000341. doi: 10.1136/bmjdrc-2016-000341. [PubMed: 28316795]. [PubMed Central: PMC5337678].
  • 27. Fathi Dizaji B. The investigations of genetic determinants of the metabolic syndrome. Diabetes Metab Syndr. 2018;12(5):783-9. doi: 10.1016/j.dsx.2018.04.009. [PubMed: 29673926].
  • 28. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97(7):2482-8. doi: 10.1210/jc.2011-3475. [PubMed: 22508708]. [PubMed Central: PMC3387408].
  • 29. Esmaillzadeh A, Mirmiran P, Azadbakht L, Amiri P, Azizi F. Independent and inverse association of hip circumference with metabolic risk factors in Tehranian adult men. Prev Med. 2006;42(5):354-7. doi: 10.1016/j.ypmed.2005.12.009. [PubMed: 16545445].
  • 30. Esmaillzadeh A, Mirmiran P, Moeini SH, Azizi F. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol. 2006;108(3):338-45. doi: 10.1016/j.ijcard.2005.05.019. [PubMed: 15963581].
  • 31. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: The AusDiab Study. Int J Obes Relat Metab Disord. 2004;28(3):402-9. doi: 10.1038/sj.ijo.0802567. [PubMed: 14724659].
  • 32. Han TS, Bijnen FC, Lean ME, Seidell JC. Separate associations of waist and hip circumference with lifestyle factors. Int J Epidemiol. 1998;27(3):422-30. doi: 10.1093/ije/27.3.422. [PubMed: 9698130].
  • 33. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6(10):2364-73. doi: 10.2215/CJN.02180311. [PubMed: 21852664]. [PubMed Central: PMC3186450].
  • 34. Kelishadi R, Hovsepian S, Djalalinia S, Jamshidi F, Qorbani M. A systematic review on the prevalence of metabolic syndrome in Iranian children and adolescents. J Res Med Sci. 2016;21:90. doi: 10.4103/1735-1995.192506. [PubMed: 28163736]. [PubMed Central: PMC5244691].
  • 35. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: A systematic review of the literature. Metab Syndr Relat Disord. 2013;11(2):71-80. doi: 10.1089/met.2012.0122. [PubMed: 23249214].
  • 36. Agudelo GM, Bedoya G, Estrada A, Patino FA, Munoz AM, Velasquez CM. Variations in the prevalence of metabolic syndrome in adolescents according to different criteria used for diagnosis: Which definition should be chosen for this age group? Metab Syndr Relat Disord. 2014;12(4):202-9. doi: 10.1089/met.2013.0127. [PubMed: 24564686].
  • 37. Lee AM, Gurka MJ, DeBoer MD. Trends in metabolic syndrome severity and lifestyle factors among adolescents. Pediatrics. 2016;137(3). e20153177. doi: 10.1542/peds.2015-3177. [PubMed: 26908664]. [PubMed Central: PMC4771130].
  • 38. Huang RC, Prescott SL, Godfrey KM, Davis EA. Assessment of cardiometabolic risk in children in population studies: Underpinning developmental origins of health and disease mother-offspring cohort studies. J Nutr Sci. 2015;4. e12. doi: 10.1017/jns.2014.69. [PubMed: 26090093]. [PubMed Central: PMC4463019].
  • 39. Mirmiran P, Sherafat-Kazemzadeh R, Farahani SJ, Asghari G, Niroomand M, Momenan A, et al. Performance of different definitions of metabolic syndrome for children and adolescents in a 6-year follow-up: Tehran lipid and glucose study (TLGS). Diabetes Res Clin Pract. 2010;89(3):327-33. doi: 10.1016/j.diabres.2010.05.001. [PubMed: 20554073].
  • 40. Bahar A, Hosseini Esfahani F, Asghari Jafarabadi M, Mehrabi Y, Azizi F. The structure of metabolic syndrome components across follow-up survey from childhood to adolescence. Int J Endocrinol Metab. 2013;11(1):16-22. doi: 10.5812/ijem.4477. [PubMed: 23853615]. [PubMed Central: PMC3693654].
  • 41. Esmaillzadeh A, Mirmiran P, Azizi F. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr. 2006;83(1):36-46. quiz 183-4. doi: 10.1093/ajcn/83.1.36. [PubMed: 16400047].
  • 42. Barzin M, Hosseinpanah F, Fekri S, Azizi F. Predictive value of body mass index and waist circumference for metabolic syndrome in 6-12-year-olds. Acta Paediatr. 2011;100(5):722-7. doi: 10.1111/j.1651-2227.2011.02162.x. [PubMed: 21244485].
  • 43. Barzin M, Asghari G, Hosseinpanah F, Mirmiran P, Azizi F. The association of anthropometric indices in adolescence with the occurrence of the metabolic syndrome in early adulthood: Tehran lipid and glucose study (TLGS). Pediatr Obes. 2013;8(3):170-7. doi: 10.1111/j.2047-6310.2012.00102.x. [PubMed: 23042576].
  • 44. Hosseinpanah F, Salehpour M, Asghari G, Barzin M, Mirmiran P, Hatami H, et al. "Adolescent metabolic phenotypes and early adult metabolic syndrome: Tehran lipid and glucose study". Diabetes Res Clin Pract. 2015;109(2):287-92. doi: 10.1016/j.diabres.2015.05.022. [PubMed: 26026779].
  • 45. Hosseinpanah F, Asghari G, Barzin M, Ghareh S, Azizi F. Adolescence metabolic syndrome or adiposity and early adult metabolic syndrome. J Pediatr. 2013;163(6):1663-16690. doi: 10.1016/j.jpeds.2013.07.032.
  • 46. Amouzegar A, Mehran L, Hasheminia M, Kheirkhah Rahimabad P, Azizi F. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran lipid and glucose study. Diabetes Metab Res Rev. 2017;33(1). doi: 10.1002/dmrr.2819. [PubMed: 27155315].
  • 47. Mozaffary A, Bozorgmanesh M, Sheikholeslami F, Azizi F, Eskandari F, Hadaegh F. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran lipid and glucose study. Eur J Clin Nutr. 2014;68(7):853-8. doi: 10.1038/ejcn.2014.91. [PubMed: 24865481].
  • 48. Hosseinpanah F, Asghari G, Barzin M, Golkashani HA, Azizi F. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults. Int J Cardiol. 2013;168(1):369-74. doi: 10.1016/j.ijcard.2012.09.037. [PubMed: 23041003].
  • 49. Hosseinpanah F, Borzooei S, Barzin M, Farshadi M, Sarvghadi F, Azizi F. Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran lipid and glucose study (TLGS). Arch Iran Med. 2012;15(10):606-10. [PubMed: 23020535].
  • 50. Ayubi E, Khalili D, Delpisheh A, Hadaegh F, Azizi F. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population. J Diabetes. 2015;7(6):830-8. doi: 10.1111/1753-0407.12252. [PubMed: 25492310].
  • 51. Zabetian A, Hadaegh F, Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp Clin Endocrinol Diabetes. 2008;116(9):525-31. doi: 10.1055/s-2008-1065332. [PubMed: 18523915].
  • 52. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Moghaddam NB, Bozorogmanesh M, et al. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the Tehran lipid and glucose study. Stroke. 2012;43(6):1669-71. doi: 10.1161/STROKEAHA.112.650812. [PubMed: 22382161].
  • 53. Hadaegh F, Zabetian A, Khalili D, Safarkhani M, Philip TJW, Azizi F. A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health. 2012;66(5):427-32. doi: 10.1136/jech.2010.117697. [PubMed: 21051780].
  • 54. Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2010;87(3):342-7. doi: 10.1016/j.diabres.2009.11.010. [PubMed: 20004035].
  • 55. Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008;80(2):328-34. doi: 10.1016/j.diabres.2008.01.003. [PubMed: 18282630].
  • 56. Santaniemi M, Ukkola O, Malo E, Bloigu R, Kesaniemi YA. Metabolic syndrome in the prediction of cardiovascular events: The potential additive role of hsCRP and adiponectin. Eur J Prev Cardiol. 2014;21(10):1242-8. doi: 10.1177/2047487313494028. [PubMed: 23787794].
  • 57. Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohn J, et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community. CMAJ. 2009;180(6):617-24. doi: 10.1503/cmaj.080972. [PubMed: 19289805]. [PubMed Central: PMC2653587].
  • 58. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165(22):2644-50. doi: 10.1001/archinte.165.22.2644. [PubMed: 16344423].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments